Market Cap 11.97B
Revenue (ttm) 0.00
Net Income (ttm) -1.08B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,105,000
Avg Vol 5,836,978
Day's Range N/A - N/A
Shares Out 776.16M
Stochastic %K 86%
Beta -1.26
Analysts Sell
Price Target $27.91

Company Profile

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 203 2034
Address:
601 Brickell Key Drive, Suite 1000, Miami, United States
TruthBroker2
TruthBroker2 Jul. 3 at 3:17 PM
0 · Reply
Void_capital
Void_capital Jul. 3 at 1:41 PM
$SMMT about time for this to start running in advance of the PDUFA
0 · Reply
TruthBroker2
TruthBroker2 Jul. 3 at 12:02 PM
$SMMT Bullish 👍
0 · Reply
TruthBroker2
TruthBroker2 Jul. 3 at 1:47 AM
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 11:11 PM
$SMMT not chasing, but definitely respecting the move
0 · Reply
georgenabi
georgenabi Jul. 2 at 8:19 PM
$SMMT heheh!
1 · Reply
TruthBroker2
TruthBroker2 Jul. 2 at 7:02 PM
$SMMT 👍
0 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:41 PM
0 · Reply
LadsAndGents
LadsAndGents Jul. 2 at 3:33 PM
$SMMT holding this for $60+
0 · Reply
Dragonland
Dragonland Jul. 2 at 2:33 PM
$SMMT I should moan about the price more often if this is the result.
0 · Reply
Latest News on SMMT
Summit Therapeutics falls -10.2%

2026-06-10T16:07:19.000Z - 24 days ago

Summit Therapeutics falls -10.2%


Summit Therapeutics Transcript: AGM 2026

Jun 10, 2026, 8:30 AM EDT - 24 days ago

Summit Therapeutics Transcript: AGM 2026


Summit Therapeutics announces $500M common stock offering

2026-06-09T20:50:10.000Z - 25 days ago

Summit Therapeutics announces $500M common stock offering


Summit Therapeutics files automatic mixed securities shelf

2026-06-09T20:35:40.000Z - 25 days ago

Summit Therapeutics files automatic mixed securities shelf


The Era of the One-Size-Fits-All Cancer Drug Is Ending

Jun 6, 2026, 5:30 AM EDT - 4 weeks ago

The Era of the One-Size-Fits-All Cancer Drug Is Ending


Summit Therapeutics Transcript: Status update

Jun 1, 2026, 7:00 AM EDT - 4 weeks ago

Summit Therapeutics Transcript: Status update


Summit Therapeutics Press release: Status update

Jun 1, 2026, 7:00 AM EDT - 4 weeks ago

Summit Therapeutics Press release: Status update


Summit Therapeutics Slides: Status update

Jun 1, 2026, 7:00 AM EDT - 4 weeks ago

Summit Therapeutics Slides: Status update


Summit Therapeutics presents new results from AK112-206 trial

2026-05-31T13:35:51.000Z - 4 weeks ago

Summit Therapeutics presents new results from AK112-206 trial


Summit Therapeutics management to meet with Cantor

2026-05-26T21:01:32.000Z - 5 weeks ago

Summit Therapeutics management to meet with Cantor


Summit Therapeutics Earnings release: Q1 2026

Apr 30, 2026, 4:00 PM EDT - 2 months ago

Summit Therapeutics Earnings release: Q1 2026


Summit Therapeutics Quarterly report: Q1 2026

Apr 30, 2026, 4:00 PM EDT - 2 months ago

Summit Therapeutics Quarterly report: Q1 2026


Summit Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Summit Therapeutics Proxy statement: Proxy filing


Summit Therapeutics Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Summit Therapeutics Proxy statement: Proxy filing


Summit Therapeutics Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Summit Therapeutics Proxy statement: Proxy filing


Summit Therapeutics to Present at Upcoming Investor Conferences

Feb 26, 2026, 6:45 PM EST - 4 months ago

Summit Therapeutics to Present at Upcoming Investor Conferences


Summit Therapeutics Earnings Call Transcript: Q4 2025

Feb 23, 2026, 4:30 PM EST - 4 months ago

Summit Therapeutics Earnings Call Transcript: Q4 2025


Summit Therapeutics Annual report: Q4 2025

Feb 23, 2026, 4:30 PM EST - 4 months ago

Summit Therapeutics Annual report: Q4 2025


Summit Therapeutics Earnings release: Q4 2025

Feb 23, 2026, 4:30 PM EST - 4 months ago

Summit Therapeutics Earnings release: Q4 2025


Summit Therapeutics Slides: Q4 2025

Feb 23, 2026, 4:30 PM EST - 4 months ago

Summit Therapeutics Slides: Q4 2025


Summit Therapeutics Raises $500 Million in Private Placement

Oct 22, 2025, 8:00 AM EDT - 9 months ago

Summit Therapeutics Raises $500 Million in Private Placement


Summit Therapeutics Earnings Call Transcript: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 9 months ago

Summit Therapeutics Earnings Call Transcript: Q3 2025


Summit Therapeutics Earnings release: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 9 months ago

Summit Therapeutics Earnings release: Q3 2025


Summit Therapeutics Quarterly report: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 9 months ago

Summit Therapeutics Quarterly report: Q3 2025


Summit Therapeutics Slides: Q3 2025

Oct 20, 2025, 8:00 AM EDT - 9 months ago

Summit Therapeutics Slides: Q3 2025


Summit Therapeutics Inc. Investigated by the Portnoy Law Firm

Sep 16, 2025, 4:31 PM EDT - 10 months ago

Summit Therapeutics Inc. Investigated by the Portnoy Law Firm


Summit Therapeutics Transcript: Study Update

Sep 8, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Transcript: Study Update


Summit Therapeutics Press release: Study Update

Sep 8, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Press release: Study Update


Summit Therapeutics Slides: Study Update

Sep 8, 2025, 8:00 AM EDT - 10 months ago

Summit Therapeutics Slides: Study Update


Summit Therapeutics Earnings release: Q2 2025

Aug 11, 2025, 7:00 AM EDT - 11 months ago

Summit Therapeutics Earnings release: Q2 2025


Summit Therapeutics Quarterly report: Q2 2025

Aug 11, 2025, 7:00 AM EDT - 11 months ago

Summit Therapeutics Quarterly report: Q2 2025


Is SMMT Stock A Buy After Its Recent Plunge?

Jun 2, 2025, 9:10 AM EDT - 1 year ago

Is SMMT Stock A Buy After Its Recent Plunge?


Final Trade: NVS, XLU and SMMT

May 1, 2025, 6:20 PM EDT - 1 year ago

Final Trade: NVS, XLU and SMMT

NVS XLU


Summit Therapeutics Earnings Call Transcript: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Summit Therapeutics Earnings Call Transcript: Q1 2025


Summit Therapeutics Quarterly report: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Summit Therapeutics Quarterly report: Q1 2025


Summit Therapeutics Earnings release: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Summit Therapeutics Earnings release: Q1 2025


Summit Therapeutics Slides: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Summit Therapeutics Slides: Q1 2025


Summit Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Summit Therapeutics Proxy statement: Proxy Filing


TruthBroker2
TruthBroker2 Jul. 3 at 3:17 PM
0 · Reply
Void_capital
Void_capital Jul. 3 at 1:41 PM
$SMMT about time for this to start running in advance of the PDUFA
0 · Reply
TruthBroker2
TruthBroker2 Jul. 3 at 12:02 PM
$SMMT Bullish 👍
0 · Reply
TruthBroker2
TruthBroker2 Jul. 3 at 1:47 AM
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 11:11 PM
$SMMT not chasing, but definitely respecting the move
0 · Reply
georgenabi
georgenabi Jul. 2 at 8:19 PM
$SMMT heheh!
1 · Reply
TruthBroker2
TruthBroker2 Jul. 2 at 7:02 PM
$SMMT 👍
0 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:41 PM
0 · Reply
LadsAndGents
LadsAndGents Jul. 2 at 3:33 PM
$SMMT holding this for $60+
0 · Reply
Dragonland
Dragonland Jul. 2 at 2:33 PM
$SMMT I should moan about the price more often if this is the result.
0 · Reply
Megabyte48
Megabyte48 Jul. 2 at 1:49 PM
$SMMT would love to see $20
0 · Reply
TruthBroker2
TruthBroker2 Jul. 2 at 1:44 PM
0 · Reply
SmokeWagon
SmokeWagon Jul. 1 at 11:47 PM
$SMMT !!!
0 · Reply
BapoRothstein
BapoRothstein Jul. 1 at 10:26 PM
$SMMT Mr. Dugan and I. Me and Rob. Chilling at Bob’s Big Boy. FTW.
0 · Reply
Dragonland
Dragonland Jul. 1 at 8:03 PM
$SMMT All that recent leadership buying has had zero effect here. Biotech sector on fire and this is still near 30% shorted and struggling to stay in double figures. It doesn't make any sense.
2 · Reply
TruthBroker2
TruthBroker2 Jul. 1 at 5:09 PM
0 · Reply
BioRich
BioRich Jul. 1 at 4:45 PM
$CRMD Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) $WVE 38) $NUVB 39) $SMMT 40) ANNX 41) CGON 42) TEM 43) IVA 44) PSN 45) LGND 46) IMVT 47) MPLT 48)NNE 49) ARDX 50) COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
4 · Reply
TruthBroker2
TruthBroker2 Jun. 30 at 5:13 PM
$SMMT Be Lookin Good👍
0 · Reply
daniela_di
daniela_di Jun. 30 at 5:46 AM
$SMMT quiet accumulation
0 · Reply
SmokeWagon
SmokeWagon Jun. 29 at 10:48 PM
$SMMT !!!
0 · Reply
TruthBroker2
TruthBroker2 Jun. 29 at 10:33 PM
0 · Reply
ArbiterOfFarts
ArbiterOfFarts Jun. 29 at 7:32 PM
$SMMT Harmoni 3, 2H2026. That’s it. That’s make or break. FDA approval is big but Harmoni 3 comes first. And it’s the biggest catalyst and test to date for SMMT. Hands down. End of story. Also look out for Auguest earnings, it will be hammered to $13 or below when they have to issue the same boiler plate legalese about funding.
0 · Reply